[Beta-blockaders for better or for worth--still a good alternative in hypertension].
Bengtsson
Calle
C
Sahlgrenska akademin, Göteborgs universitet. calleb@allmed.gu.se
Sigurdsson
Jöhann A
JA
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D012307:Risk Factors; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents